Healthcare provider profile · identity verified

Dipak V Vashi, MD

Internal Medicine · ATLANTA, GA · NPI 1457372799

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1525	450
Rosuvastatin Calcium	Rosuvastatin Calcium	642	213
Amlodipine Besylate	Amlodipine Besylate	582	175
Levothyroxine Sodium	Levothyroxine Sodium	494	141
Lisinopril	Lisinopril	468	128
Omeprazole	Omeprazole	435	145
Metformin Hcl Er	Metformin Hcl	370	107
Losartan Potassium	Losartan Potassium	349	111
Tramadol Hcl	Tramadol Hcl	322	94
Trazodone Hcl	Trazodone Hcl	312	116
Finasteride	Finasteride	286	84
Famotidine	Famotidine	275	97
Fluticasone Propionate	Fluticasone Propionate	271	131
Tamsulosin Hcl	Tamsulosin Hcl	264	83
Zolpidem Tartrate	Zolpidem Tartrate	255	92
Pantoprazole Sodium	Pantoprazole Sodium	244	81
Metoprolol Succinate	Metoprolol Succinate	242	75
Pioglitazone Hcl	Pioglitazone Hcl	160	43
Simvastatin	Simvastatin	149	41
Gabapentin	Gabapentin	144	63
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	144	37
Allopurinol	Allopurinol	143	46
Sertraline Hcl	Sertraline Hcl	133	36
Alprazolam	Alprazolam	124	43
Escitalopram Oxalate	Escitalopram Oxalate	123	41
Ozempic	Semaglutide	123	25
Carvedilol	Carvedilol	114	34
Albuterol Sulfate Hfa	Albuterol Sulfate	107	46
Azelastine Hcl	Azelastine Hcl	107	39
Duloxetine Hcl	Duloxetine Hcl	98	32
Bupropion Xl	Bupropion Hcl	97	42
Glimepiride	Glimepiride	97	30
Synthroid	Levothyroxine Sodium	90	24
Metformin Hcl	Metformin Hcl	89	31
Celecoxib	Celecoxib	87	25
Jardiance	Empagliflozin	86	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	85	15
Clopidogrel	Clopidogrel Bisulfate	80	25
Olmesartan Medoxomil	Olmesartan Medoxomil	80	27
Mounjaro	Tirzepatide	79	14
Hydrochlorothiazide	Hydrochlorothiazide	76	24
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	76	57
Fluoxetine Hcl	Fluoxetine Hcl	75	25
Valsartan	Valsartan	71	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	70	21
Montelukast Sodium	Montelukast Sodium	70	21
Lorazepam	Lorazepam	68	14
Pravastatin Sodium	Pravastatin Sodium	67	22
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	66	18
Citalopram Hbr	Citalopram Hydrobromide	64	16
Atenolol	Atenolol	63	19
Alendronate Sodium	Alendronate Sodium	60	20
Meloxicam	Meloxicam	60	31
Ipratropium Bromide	Ipratropium Bromide	55	20
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	54	15
Ibandronate Sodium	Ibandronate Sodium	53	19
Tizanidine Hcl	Tizanidine Hcl	53	13
Ondansetron Hcl	Ondansetron Hcl	51	28
Promethazine Hcl	Promethazine Hcl	51	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	49	13
Furosemide	Furosemide	49	17
Xarelto	Rivaroxaban	49	suppressed
Clonazepam	Clonazepam	48	11
Diclofenac Sodium	Diclofenac Sodium	47	19
Hydroxyzine Hcl	Hydroxyzine Hcl	47	20
Memantine Hcl	Memantine Hcl	47	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	46	17
Ramipril	Ramipril	44	12
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	43	13
Ezetimibe	Ezetimibe	42	17
Sumatriptan Succinate	Sumatriptan Succinate	42	suppressed
Valacyclovir	Valacyclovir Hcl	41	27
Baclofen	Baclofen	40	13
Quetiapine Fumarate	Quetiapine Fumarate	39	suppressed
Spironolactone	Spironolactone	39	15
Donepezil Hcl	Donepezil Hcl	38	suppressed
Eliquis	Apixaban	38	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	38	suppressed
Wegovy	Semaglutide	38	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	37	11
Benazepril Hcl	Benazepril Hcl	35	11
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	35	suppressed
Trulicity	Dulaglutide	34	suppressed
Diazepam	Diazepam	32	12
Amoxicillin	Amoxicillin	29	26
Azithromycin	Azithromycin	29	24
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	suppressed
Breo Ellipta	Fluticasone/Vilanterol	28	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	28	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	28	28
Methylprednisolone	Methylprednisolone	26	14
Mometasone Furoate	Mometasone Furoate	26	18
Nifedipine Er	Nifedipine	26	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	26	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Potassium Chloride	Potassium Chloride	26	suppressed
Irbesartan	Irbesartan	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	25	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	16
Eszopiclone	Eszopiclone	23	suppressed
Testosterone Cypionate	Testosterone Cypionate	23	suppressed
Acarbose	Acarbose	21	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Telmisartan	Telmisartan	20	suppressed
Acyclovir	Acyclovir	19	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	19	suppressed
Estradiol	Estradiol	19	suppressed
Hydrocortisone	Hydrocortisone	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	18	suppressed
Topiramate	Topiramate	18	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	17	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	16	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	11
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	16	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	16	suppressed
Nystatin	Nystatin	16	suppressed
Prednisone	Prednisone	16	13
Rizatriptan	Rizatriptan Benzoate	16	suppressed
Etodolac	Etodolac	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	15	suppressed
Temazepam	Temazepam	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	13	11
Labetalol Hcl	Labetalol Hcl	13	suppressed
Phenobarbital	Phenobarbital	13	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	13	suppressed
Fentanyl	Fentanyl	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Cefuroxime	Cefuroxime Axetil	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Imipramine Hcl	Imipramine Hcl	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Zonisamide	Zonisamide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error